Aurobindo Pharma Limited announced its participation in the ICICI Securities India Investor Conference. The meeting is scheduled to take place in Mumbai on June 8, 2026, from 10:00 to 18:00 IST. The company officials will engage in in-person and group meetings during the conference. The schedule is subject to change based on exigencies from the investor or the company. Aurobindo Pharma has confirmed that no unpublished price-sensitive information (UPSI) will be discussed during these interactions. This engagement is part of the company's ongoing efforts to communicate with investors and provide updates on its business.
